SCHEMBL15020330

SCHEMBL15020330

CCN(c1ccc(/N=C2/C=C(Nc3ccc(N(CC)C(C)C)cc3)C(=O)C(OC)=C2Nc2ccc(N(CC)C(C)C)cc2)cc1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.39
▸ ALDH1A1 P00352 14/20 0.37
▸ L3MBTL1 Q9Y468 11/20 0.37
▸ MAPT P10636 11/20 0.37
▸ MAPK1 P28482 7/20 0.37
▸ HPGD P15428 6/20 0.37
▸ LMNA P02545 6/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ HTT P42858 5/20 0.37
▸ TDP1 Q9NUW8 5/20 0.37
▸ NSD2 O96028 2/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ POLB P06746 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RECQL P46063 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ MCL1 Q07820 5/20 0.35
▸ KMT2A Q03164 6/20 0.35
▸ GPR55 Q9Y2T6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15019794 1.00 IDO1 (0.39) IDO1ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL15020256 0.90 IDO1 (0.37) IDO1ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL15020258 0.90 IDO1 (0.37) IDO1ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL17253312 0.85 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPTMAPK1HPGD
SCHEMBL15020129 0.81 ALDH1A1 (0.37) ALDH1A1L3MBTL1MAPTMAPK1HPGD
SCHEMBL17253269 0.81 ALDH1A1 (0.37) ALDH1A1L3MBTL1MAPTMAPK1HPGD
SCHEMBL15020128 0.81 ALDH1A1 (0.37) ALDH1A1L3MBTL1MAPTMAPK1HPGD
SCHEMBL15019814 0.80 APAF1 (0.39) IDO1ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL15019813 0.80 APAF1 (0.39) IDO1ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL15039564 0.80 APAF1 (0.39) IDO1ALDH1A1L3MBTL1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
EP-2791252-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2014-10-22 — — EP disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 IDO1 238/4885ALDH1A1 235/4885L3MBTL1 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback